Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.92
+4.23 (90.19%)
At close: Jun 6, 2025, 4:00 PM
8.90
-0.02 (-0.22%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Phathom Pharmaceuticals Revenue
Phathom Pharmaceuticals had revenue of $28.52M in the quarter ending March 31, 2025, with 1,391.58% growth. This brings the company's revenue in the last twelve months to $81.86M, up 3,055.71% year-over-year. In the year 2024, Phathom Pharmaceuticals had annual revenue of $55.25M with 8,001.47% growth.
Revenue (ttm)
$81.86M
Revenue Growth
+3,055.71%
P/S Ratio
7.25
Revenue / Employee
$191,707
Employees
427
Market Cap
621.26M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
PHAT News
- 20 hours ago - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 - GlobeNewsWire
- 23 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025 - GlobeNewsWire
- 7 weeks ago - Frazier Life Sciences Appoints Aditya Kohli to Partner - Business Wire